Antiseizure medications for primary and secondary seizure prevention after stroke
Post-stroke seizures (PSS) and post-stroke epilepsy (PSE) are serious complications of cerebrovascular disease, contributing to morbidity, delayed recovery, cognitive decline, and mortality. PSS are classified as early (within 7 days) or late (after 7 days), with late-onset seizures often signaling...
Saved in:
| Main Authors: | Zoe C. Wolcott, Brin E. Freund, William O. Tatum, Anteneh M. Feyissa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1648064/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SEIZURES AS THE DEBUT SYMPTOMS OF ACUTE PAEDIATRIC STROKE
by: L. V. Shalkevich, et al.
Published: (2016-05-01) -
Early-Onset Seizures in Ischemic Stroke: A Descriptive Cross-Sectional Study
by: Mohsina Syed, et al.
Published: (2022-07-01) -
Antiseizure medication choice in diffuse glioma: A single‐center population‐based experience
by: Leena Ollila, et al.
Published: (2025-06-01) -
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
by: Maria Luiza Giraldes de MANREZA, et al.
Published: (2021-06-01) -
Stroke-related epilepsy in the rehabilitation setting: Insights from the inpatient post-stroke rehabilitation study – RIPS
by: Maenia Scarpino, et al.
Published: (2024-01-01)